October 18, 2020
In this month’s update, we’re excited to share that Citizens United for Research in Epilepsy, or CURE, has been renamed to CURE Epilepsy™. Our new name and logo reinforces our continued unrelenting commitment to promoting and funding patient-focused research to find a cure for epilepsy.
Last month, we celebrated the epilepsy community around the world with our first ever virtual event Unite to CURE Epilepsy. Among others, Dr. Sanjay Gupta, the Chief Medical Correspondent at CNN and practicing neurosurgeon, spoke about the importance of continuing to fund epilepsy research, especially during this pandemic. You can hear his message here.
In addition, please read on to find information on:
As part of our commitment to supporting the research community through these challenging times, we have launched a virtual seminar series. Our next seminar is fast approaching on the Biological Mechanisms of SUDEP, in support of SUDEP Action day. Submit any questions you have live or ahead of time here. Mark your calendars!
In addition, Drs. Robert Hunt and Momoko Watanabe of University of California – Irvine are hosting a seminar series featuring early-career investigators. You can find more information about the topics they will cover here.
Every seven years stakeholders from across the world of epilepsy review and adjust the Epilepsy Research Benchmarks. These Benchmarks inform the epilepsy communities’ collective research priorities. You have until October 30 to share your voice and help shape the way for the next five-to-seven years of epilepsy advances.
Looking to familiarize yourself with the NIH’s grants process, programs, and policies? From October 27 – 30, the NIH will be hosting a virtual seminar highlighting key information to help applicants further understand the NIH grant funding process.
This virtual seminar is designed for those who are new to the NIH grants process, with additional sessions for those who are focused on more in-depth policies and procedures.
Metabolism-based therapies are an age-old method of treating epilepsy. Despite this, the mechanisms underlying the efficacy of these treatments are not thoroughly understood and conducting rigorous studies is challenging. Learn more about the issues from the research point of view, with the aim of further identifying those that can be addressed in future studies.